At a glance
Antiglaucoma medications during pregnancy
Ho et al studied the relationship between use of antiglaucoma medications during pregnancy and the risk of having low-birth-weight (LBW) infants in 244 pregnant women who had been prescribed topical glaucoma medication during pregnancy. The control group comprised of 1952 pregnant women matched for age, year of delivery, maternal hypertension, and gestational diabetes. The majority of pregnant women (78%) were prescribed beta-blockers to control glaucoma. After adjusting for confounding variables, there was no significant difference in the risk of LBW infants between mothers prescribed beta-blockers and the comparison cohort (OR 1.48). However, there was a significantly higher risk of LBW infants for mothers prescribed topical antiglaucoma medications other than beta-blockers (OR 2.1). The authors conclude that topical beta-blockers can be the first-line drugs for medical treatment of glaucoma in a pregnant woman.
See pages 1283
ReSTOR IOL in adult anisometropic and amblyopic patients
Petermeier et al assessed subjective and objective parameters of visual function after implantation of the AcrySof …
